Drug intelligence / Profile preview

Lyconize

Development stage
Unknown
Lead developer
SBM Enterprises
Modality
Small Molecules
Administration
Oral
01

Overview

Lyconize is a multi-ingredient antioxidant dietary supplement developed and marketed by SBM Enterprises (also known as SBM Pharmaceuticals). It is available as a finished formulation in softgel capsule form. The product contains a combination of active ingredients including lycopene (an antioxidant carotenoid), black grape seed extract, lutein, beta-carotene, and selenium dioxide monohydrate, along with various vitamins and minerals. According to the company's product information, the formulation contains lycopene 10% USP 4000mcg, black grape seed extract 10mg, lutein 10% USP 4000 mcg, beta-carotene 30% USP 5.17mg, and selenium dioxide monohydrate USP 25 mcg. This product is marketed for general nutritional supplementation and antioxidant support. As a finished formulation marketed by a PCD (Propaganda Cum Distribution) pharma company, it is positioned as a branded generic nutraceutical rather than an investigational pharmaceutical drug.

Brand names
Lyconize

Beyond the preview

Go deeper on Lyconize.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyconize.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call